Personalized Medicine and Molecular Interaction Networks in Amyotrophic Lateral Sclerosis (ALS): Current Knowledge

Area of Science:

• Neuroscience
• Genomics
• Systems Biology

Background:

• Amyotrophic lateral sclerosis (ALS) is a complex, systemic disease involving multiple genes and pathophysiological mechanisms.
• Current understanding necessitates exploring advanced analytical approaches for effective treatment strategies.

Purpose of the Study:

• To review omics datasets and analytical methods for molecular interaction networks in ALS.
• To explore the potential of network analysis in understanding ALS pathophysiology and identifying therapeutic targets.

Main Methods:

• Review of existing omics datasets relevant to ALS.
• Analysis of computational approaches for molecular interaction network modelling.
• Examination of network properties to identify disease-associated pathways.

Main Results:

• Molecular interaction networks offer a framework for integrating diverse omics data in ALS.
• Network analysis can highlight key pathways and potential therapeutic targets.
• This approach supports the development of personalized medicine (PM) strategies for ALS.

Conclusions:

• Understanding ALS requires a systems-level approach, integrating multi-omics data.
• Molecular network analysis is a promising strategy for discovering novel ALS therapeutic targets.
• Personalized medicine (PM) approaches informed by network analysis may improve ALS patient outcomes.